CompaniesRanked

2874 companies · fiscal year 2025 · SEC EDGAR · September 25, 2026

Healthcare companies with the most cash — page 2

Ranks 101–200 of 321 · Fiscal year 2025 · Data as of September 25, 2026

Cash
#CompanyCashYoY15-year trend
101BilliontooneBLLNUS$496M+159.0%
102Transmedics GroupTMDXUS$489M+45.0%
103Sinovac BiotechSVACN$488M+45.6%
104ExelixisEXELUS$482M+122.0%
105Privia HealthPRVAUS$480M−2.3%
106Immunocore HoldingsIMCRGB$468M+2.6%
107Merit Medical SystemsMMSIUS$446M+18.5%
108SterisSTEIE$424M+173.0%
109Ultragenyx PharmaceuticalRAREUS$421M+142.0%
110Quest DiagnosticsDGXUS$420M−23.5%
111AlkermesALKSIE$389M+33.5%
112Bausch & LombBLCOCA$383M+25.6%
113TeleflexTFXUS$379M+52.7%
114Guardant HealthGHUS$378M−28.0%
115Pediatrix MedicalMDUS$375M+63.2%
116Ionis PharmaceuticalsIONSUS$372M+53.8%
117Opko HealthOPKUS$364M−14.6%
118HaemoneticsHAEUS$363M+13.3%
119VeracyteVCYTUS$363M+51.7%
120Lantheus HoldingsLNTHUS$359M−60.7%
121HerbalifeHLFKY$353M−15.0%
122Sotera HealthSHCUS$345M+24.3%
123Dentsply SironaXRAYUS$326M+19.9%
124Axsome TherapeuticsAXSMUS$323M+2.4%
125Icu MedicalICUIUS$308M−0.2%
126InmodeINMDIL$303M+94.8%
127Mirum PharmaceuticalsMIRMUS$297M+33.3%
128Beam TherapeuticsBEAMUS$295M+4.6%
129Keros TherapeuticsKROSUS$287M−48.7%
130Procept BioroboticsPRCTUS$287M−14.1%
131Warby ParkerWRBYUS$286M+12.7%
132Ani PharmaceuticalsANIPUS$286M+97.1%
133Amneal PharmaceuticalsAMRXUS$282M+155.1%
134Brookdale Senior LivingBKDUS$279M−9.6%
135Canopy GrowthCGCCA$271M+141.0%
136Community Health SystemsCYHUS$260M+602.7%
137Trulieve CannabisTRLVUS$256M+7.0%
138CryoportCYRXUS$250M+633.8%
139GrailGRALUS$250M+16.6%
140Lifestance HealthLFSTUS$249M+60.9%
141NovavaxNVAXUS$241M−54.6%
142Surgery PartnersSGRYUS$240M−11.0%
143Nu Skin EnterprisesNUSUS$239M+27.7%
144Irhythm HoldingsIRTCUS$236M−43.8%
145Integra LifesciencesIARTUS$235M−4.6%
146Skinhealth SystemsSKINUS$233M−37.1%
147Option Care HealthOPCHUS$233M−43.6%
148Collegium PharmaceuticalCOLLUS$231M+227.7%
149SchrodingerSDGRUS$231M+56.5%
150Hims & Hers HealthHIMSUS$229M+3.6%
151Omada HealthOMDAUS$222M+190.7%
152Arcus BiosciencesRCUSUS$222M+48.0%
153Tilray BrandsTLRYUS$222M+10.9%
154Maravai LifesciencesMRVIUS$217M−32.7%
155Ironwood PharmaceuticalsIRWDUS$215M+143.3%
156Charles River Laboratories InternationalCRLUS$214M+9.8%
157Emergent BiosolutionsEBSUS$205M+106.4%
158Arrowhead PharmaceuticalsARWRUS$202M+274.2%
159EmbectaEMBCUS$201M−4.1%
160Madrigal PharmaceuticalsMDGLUS$199M+98.7%
161Pacs GroupPACSUS$197M+25.0%
162Indivior PharmaceuticalsINDVUS$195M−38.9%
163Aveanna HealthcareAVAHUS$193M+129.3%
164LiquidiaLQDAUS$191M+8.0%
165PenumbraPENUS$187M−42.4%
166Akebia TherapeuticsAKBAUS$185M+256.4%
167SNDLSNDLCA$184M+21.4%
168Tarsus PharmaceuticalsTARSUS$184M+93.7%
169Idexx LaboratoriesIDXXUS$180M−37.5%
170Acadia PharmaceuticalsACADUS$178M−44.4%
171Ligand PharmaceuticalsLGNDUS$175M+141.9%
172Fortrea HoldingsFTREUS$175M+47.3%
173Agilon HealthAGLUS$174M−7.7%
174Bio-TechneTECHUS$173M−2.6%
175AlvotechALVOLU$172M+235.1%
176Amphastar PharmaceuticalsAMPHUS$170M+12.2%
177QuidelorthoQDELUS$170M+72.7%
178AtricureATRCUS$167M+36.4%
179Ginkgo BioworksDNAUS$167M−70.2%
180Mimedx GroupMDXGUS$166M+59.1%
181Kiniksa Pharmaceuticals InternationalKNSAGB$166M−9.8%
182Msa SafetyMSAUS$165M+0.3%
183SBC Medical GroupSBCUS$164M+31.0%
184Iovance BiotherapeuticsIOVAUS$163M+41.0%
185Alphatec HoldingsATECUS$161M+15.8%
186Pacira BiosciencesPCRXUS$159M−42.7%
187Usana Health SciencesUSNAUS$158M−12.9%
188Unum GroupUNMUS$158M−2.8%
189Stevanato GroupSTVNIT$153M+50.3%
190Staar SurgicalSTAAUS$153M+6.2%
191Myriad GeneticsMYGNUS$150M+46.1%
192Twist BioscienceTWSTUS$149M−32.9%
193NeogenNEOGUS$145M+3.6%
194Pharming GroupPHARNL$145M+164.5%
195CormedixCRMDUS$145M+256.3%
196ArvinasARVNUS$143M+42.2%
197Telix PharmaceuticalsTLXAU$142M−67.8%
198Bright Horizons Family SolutionsBFAMUS$140M+27.0%
199AnaptysbioANABUS$138M+498.8%
200TrupanionTRUPUS$138M−13.9%

All figures from SEC filings · FY2025 · 100

see sources

Download this data as a CSV →

Companies with the most cash →

By sector

By country